Det produceres af en bakterie, der har modtaget et gen (DNA), som sætter den i stand til at producere insulin glargin.
The active substance in Optisulin, insulin glargine, is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glargine.